CellBion Co., Ltd. (KOSDAQ:308430)
South Korea · Delayed Price · Currency is KRW 12,200
+30 (0.25%)
At close: Nov 13, 2026
CellBion Market Cap
CellBion has a market cap or net worth of 157.44 billion as of November 13, 2026. It is the 24,043rd most valuable company in the world and the 964th biggest in South Korea. Its market cap has decreased by 33.31% in one year.
Market Cap
157.44B
Enterprise Value
120.13B
Revenue
2.15B
Global Rank
Country Rank
#964 South Korea
PE Ratio
20.65
ChartMarket Cap Chart
Since October 16, 2024, CellBion's market cap has decreased from 263.06B to 157.44B, a decrease of -40.15%. That is a compound annual growth rate of -21.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 157.44B | -48.01% |
| Dec 30, 2025 | 302.82B | 100.48% |
| Dec 30, 2024 | 151.05B | -42.58% |
| Oct 16, 2024 | 263.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 227.13B |
| Vivozon Pharmaceutical | 180.49B |
| DAE HWA Pharmaceutical | 170.22B |
| HEM Pharma | 168.69B |
| GC WellBeing | 167.71B |
| NOVAREX | 151.38B |
| Kyung Dong Pharmaceutical | 144.45B |
| PHARMARESEARCH BIO | 117.48B |